Clinical Trial Update: Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris [Phase 1]

View source ↗

Summary

A Phase 1 study compared a generic adapalene/benzoyl peroxide gel (0.1%/2.5%) with Epiduo and placebo in acne vulgaris; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• Adapalene/Benzoyl Peroxide Gel 0.1%/2.5% (adapalene + benzoyl peroxide)
• EPIDUO (adapalene and benzoyl peroxide)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Acne Vulgaris | Phase 1 | Status: COMPLETED